A systematic review on the therapeutic relevance of hydroxychloroquine/chloroquine in the management of COVID-19
Conclusions: Considering the known safety profile of these drugs in the treatment of other diseases, their availability and affordability, chloroquine and hydroxychloroquine are potential antiviral agents in the treatment of COVID-19. However, reported side effects of these drugs when used in conjunction with azithromycin in patients with comorbidities have raised significant safety concerns. High-quality randomized clinical trials are warranted to provide more comprehensive evidence of the safety of these drugs in patients infected with COVID-19.
Source: Indian Journal of Community Medicine - Category: International Medicine & Public Health Authors: Gerard Mccabe Dhruv Satya Sahni Srishti Ramsaha Source Type: research
More News: Azithromycin | Clinical Trials | Coronavirus | COVID-19 | Databases & Libraries | Emergency Medicine | Hydroxychloroquine | India Health | International Medicine & Public Health | Pandemics | Study | Vaccines | Zithromax